Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Beta-Cyclodextrin API

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 149Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cyclo Therapeutics Sign Master Services Agreement with Worldwide Clinical Trials
    Cyclo Therapeutics Sign Master Services Agreement with Worldwide Clinical Trials

    30 Dec 2019

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20191227005025/en

    BUSINESS WIRE
    30 Dec 2019
    Share Share
    Evaluation of taste masking effect of diclofenac using sweeteners & cyclodextrin
    Evaluation of taste masking effect of diclofenac using sweeteners & cyclodextrin

    20 Sep 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/09/20/evaluation-of-taste-masking-effect-of-diclofenac-using-sweeteners-and-cyclodextrin-by-a-potentiometric-electronic-tongue/

    PHARMA-EXCIPIENTS
    20 Sep 2016
    Share Share
    Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
    Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells

    24 May 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/05/25/cytotoxicity-of-different-excipients-on-rpmi-2650-human-nasal-epithelial-cells/

    PHARMA-EXCIPIENTS
    24 May 2016
    Share Share